DK0565665T3 - Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider - Google Patents

Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider

Info

Publication number
DK0565665T3
DK0565665T3 DK92921544T DK92921544T DK0565665T3 DK 0565665 T3 DK0565665 T3 DK 0565665T3 DK 92921544 T DK92921544 T DK 92921544T DK 92921544 T DK92921544 T DK 92921544T DK 0565665 T3 DK0565665 T3 DK 0565665T3
Authority
DK
Denmark
Prior art keywords
prothrombin time
recombinant human
preparation
human factor
synthetic phospholipids
Prior art date
Application number
DK92921544T
Other languages
Danish (da)
English (en)
Inventor
Pamela L Hawkins
Liliana Tejidor
James Maynard
Kevin B Johnson
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of DK0565665T3 publication Critical patent/DK0565665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK92921544T 1991-10-04 1992-09-25 Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider DK0565665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77129491A 1991-10-04 1991-10-04
PCT/US1992/008281 WO1993007492A1 (en) 1991-10-04 1992-09-25 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids

Publications (1)

Publication Number Publication Date
DK0565665T3 true DK0565665T3 (da) 1998-09-28

Family

ID=25091357

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92921544T DK0565665T3 (da) 1991-10-04 1992-09-25 Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider

Country Status (11)

Country Link
US (1) US5625036A (de)
EP (1) EP0565665B1 (de)
JP (1) JP3416778B2 (de)
AT (1) ATE163768T1 (de)
AU (1) AU663343B2 (de)
CA (1) CA2097199C (de)
DE (1) DE69224622T2 (de)
DK (1) DK0565665T3 (de)
ES (1) ES2115679T3 (de)
NZ (1) NZ244597A (de)
WO (1) WO1993007492A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418141A (en) * 1994-05-06 1995-05-23 Avocet Medical, Inc. Test articles for performing dry reagent prothrombin time assays
IL115849A0 (en) * 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
AT403437B (de) * 1995-02-15 1998-02-25 Immuno Ag Physiologisch aktive gewebefaktor-präparation
EP0862742B1 (de) * 1995-11-22 2003-06-11 Oklahoma Medical Research Foundation Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
US5858724A (en) * 1996-07-16 1999-01-12 Pel-Freez Recombinant rabbit tissue factor
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
WO1998048283A1 (en) * 1997-04-23 1998-10-29 Instrumentation Laboratory S.P.A. Recombinant rabbit tissue factor based prothrombin time reagent
AU9114598A (en) * 1997-08-26 1999-03-16 University Of North Carolina At Chapel Hill, The Method of monitoring blood low molecular weight heparin and heparin
US6245573B1 (en) 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
EP2042610A1 (de) 1999-02-23 2009-04-01 Asulab S.A. Elektrochemisches System zur Bestimmung der Koagulationszeit von Blut
US6733985B1 (en) * 1999-05-19 2004-05-11 International Technidyne Corporation Preparation of stable liquid and dried synthetic prothrombin time reagents
ATE268477T1 (de) * 1999-09-03 2004-06-15 Roche Diagnostics Corp Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
US6248353B1 (en) * 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
US7358337B2 (en) * 2002-08-16 2008-04-15 International Technidyne Corporation Assay for low molecular weight heparin
US7049087B2 (en) * 2002-11-05 2006-05-23 Lifescan, Inc. Method for manufacturing a tissue factor-based prothrombin time reagent
US20060110283A1 (en) * 2002-11-12 2006-05-25 Inverness Medical Switzerland Gmbh Photometric determination of coagulation time in undiluted whole blood
WO2004043991A2 (en) * 2002-11-13 2004-05-27 Haematologic Technologies, Inc. Assay for tissue factor and factor viia
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
AT501650A1 (de) * 2005-02-22 2006-10-15 Technoclone Ges M B H Verfahren zur bestimmung der gerinnungsaktivierung sowie gerät zur durchführung des verfahrens
JP2008531692A (ja) 2005-03-04 2008-08-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ 凝固及び線維素溶解カスケードのモジュレーター
JP5073270B2 (ja) 2006-11-14 2012-11-14 シスメックス株式会社 凝固検査用試薬及びその製造方法
EP2040073A1 (de) 2007-09-20 2009-03-25 Iline Microsystems, S.L. Mikrofluidische Vorrichtung und Verfahren zur Flüssigkeitsgerinnungs-Zeitbestimmung
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
WO2011144953A1 (en) * 2010-05-18 2011-11-24 Diagon Kft. Procedure for producing recombinant human tissue factor
WO2011148207A1 (en) 2010-05-28 2011-12-01 Diagon Kft. Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
CN102608337B (zh) * 2011-04-22 2014-05-14 武汉塞力斯生物技术有限公司 凝血酶原时间测定试剂盒及其制备方法
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法
CN115508569A (zh) * 2022-09-15 2022-12-23 上海太阳生物技术有限公司 蛋白s试剂及检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
SE458342B (sv) * 1987-07-06 1989-03-20 Alfa Laval Ab Centrifugalseparator innefattande en rotor med en separeringskammare bestaaende av tvaa avdelningar
US4865984A (en) * 1988-02-08 1989-09-12 Mount Sinai School Of Medicine Of The City University Of New York Dynamic continuous flow enzyme reactor
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent

Also Published As

Publication number Publication date
CA2097199A1 (en) 1993-04-05
CA2097199C (en) 2001-05-08
ES2115679T3 (es) 1998-07-01
EP0565665B1 (de) 1998-03-04
US5625036A (en) 1997-04-29
JP3416778B2 (ja) 2003-06-16
NZ244597A (en) 1993-09-27
DE69224622D1 (de) 1998-04-09
WO1993007492A1 (en) 1993-04-15
DE69224622T2 (de) 1998-11-05
EP0565665A1 (de) 1993-10-20
AU663343B2 (en) 1995-10-05
JPH06505562A (ja) 1994-06-23
AU2769292A (en) 1993-05-03
ATE163768T1 (de) 1998-03-15

Similar Documents

Publication Publication Date Title
DK0565665T3 (da) Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider
DE3687402D1 (de) Thrombinzusammensetzung.
DE68918155D1 (de) Chirurgisches Klebstoffmaterial.
Shomers et al. Properties of cysteine-containing phosphoproteins from human submandibular-sublingual saliva
AT338429B (de) Zur verankerung von implantaten und gelenkendoprothesen im knochen dienende mischung
ES2070312T3 (es) Vacuna de proteina de membrana exterior meningococica de clase 1.
ATE136221T1 (de) Osteo-induktive pharmazeutische formulierungen
DE3484933D1 (de) Implantat zur befestigung von zahnprothesen.
ES2063965T3 (es) Vacunas para haemophilus influenzae no tipificable.
MY103518A (en) Steroid 5- -reductase inhibitors
UA39174C2 (uk) Асоціати депротонованої гіалуронової кислоти, спосіб одержання асоціатів депротонованої гіалуронової кислоти, фармацевтична композиція та спосіб одержання фармацевтичної композиції
DE58900119D1 (de) Chirurgisches instrument zum einsetzen von hueftpfannen-prothesen.
AT388096B (de) Implantat zur befestigung von zahnprothesen
PT77213A (de) Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ATE78042T1 (de) Analoge des humanen relaxins.
DE3486081D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE3855810D1 (de) Dispersion von Kalzium-Karbonat in Glycol
NO306609B1 (no) I det vesentlige sfaerisk vateritt og fremgangsmåte for fremstilling derav
DE69306915D1 (de) Kombination zur Detektion von Weichgewebeanomalien
HU912486D0 (en) Process for producing ethers and thioethers of piperidyl
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
ATE106097T1 (de) Verwendung von gyrasehemmern zur dekontamination von mycoplasma-infizierten zellkulturen.
Psuja et al. Binding of heparin to human endothelial cell monolayer and extracellular matrix in culture
GR3020389T3 (en) Calibrator and use thereof in an immuno-assay